eScholarshipmetadata only
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
32 biomedical and clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), biomedical imaging (rcdc), women's health (rcdc), prevention (rcdc), cancer (rcdc), genetics (rcdc), precision medicine (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 784370
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.